John A. Fallon - 16 May 2024 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Role: Director
Signature: /s/ Shirley R. Kuhlmann as Attorney-in-Fact for John A. Fallon, MD
Issuer symbol: COLL
Transactions as of: 16 May 2024
Net transactions value: $0
Form type: 4
Filing time: 16 May 2024, 19:22:21 UTC
Previous filing: 19 May 2023
Next filing: 19 May 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	COLL	Common Stock	Award	$0	+7,693	+16%	$0.000000	54,843	16 May 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on May 16, 2025, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock.

Content

Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on May 16, 2025, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock.